{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:25:53Z","timestamp":1790886353669,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Mesonephric-like adenocarcinoma is a recently described rare neoplasm occurring in the uterine corpus and ovary. This under-recognized subtype of carcinoma can be very challenging to diagnose. In mesonephric adenocarcinoma a variety of growth patterns can be present within the same tumor, as a result of which they can be misinterpreted and diagnosed as low-grade endometrioid adenocarcinoma, clear cell carcinoma, or even serous carcinoma and carcinosarcoma. We report a case of mesonephric-like adenocarcinoma misdiagnosed as a low-grade endometrioid endometrial adenocarcinoma that had an early local recurrence and metastasized to the liver and the lungs. Histopathological, immunohistochemical and molecular analysis were performed and compared to published literature, providing a comprehensive overview of the current knowledge. Databases (Pubmed, Web of Science, Google Scholar) were searched with a combination of the following search terms: mesonephric-like, mesonephric, adenocarcinoma, carcinoma, uterine body, uterine corpus, endometrium. Mesonephric-like adenocarcinoma is a difficult-to-diagnose entity. Advanced diagnostics, including improved morphologic, immunohistochemical and molecular knowledge can help develop new therapeutic strategies against this specific subtype of endometrial cancer with an aggressive clinical behavior.<\/jats:p>","DOI":"10.3390\/jcm10040698","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T16:12:10Z","timestamp":1613146330000},"page":"698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Mesonephric-Like Adenocarcinoma of the Endometrium: Diagnostic Advances to Spot This Wolf in Sheep\u2019s Clothing. A Review of the Literature"],"prefix":"10.3390","volume":"10","author":[{"given":"Ellen","family":"Deolet","sequence":"first","affiliation":[{"name":"Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8175-2930","authenticated-orcid":false,"given":"Jo","family":"Van Dorpe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"Cancer Research Institute Ghent (CRIG), Ghent University, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-9790","authenticated-orcid":false,"given":"Koen","family":"Van de Vijver","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"Cancer Research Institute Ghent (CRIG), Ghent University, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a m\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like Adenocarcinoma: Further evidence for a mullerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.10.005","article-title":"Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers","volume":"108","author":"Gibbard","year":"2020","journal-title":"Human Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"429443","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: A subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: Report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pors, J., Segura, S., Chiu, D.S., Almadani, N., Ren, H., Fix, D.J., Howitt, B.E., Kolin, D., McCluggage, W.G., and Mirkovic, J. (2020). Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: A multi-institutional study. Am. J. Surg. Pathol.","DOI":"10.1097\/PAS.0000000000001612"},{"key":"ref_11","unstructured":"WHO (2020). Classification of Tumours Editorial Board. WHO Classification of Tumours: Female Genital Tumours, WHO. [5th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1827.1995.tb03461.x","article-title":"Carcinosarcoma of the uterine body of mesonephric origin","volume":"45","author":"Yamamoto","year":"1995","journal-title":"Pathol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation","volume":"25","author":"Ordi","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0090-8258(03)00228-2","article-title":"Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus","volume":"90","author":"Montagut","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: A clinicopathologic study of 9 cases","volume":"28","author":"Prat","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","first-page":"1450","article-title":"Second case of uterine mesonephric adenocarcinoma","volume":"16","author":"Marquette","year":"2006","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PGP.0b013e318166067f","article-title":"Mesonephric adenocarcinoma of the uterine corpus: A case report and review of the literature","volume":"27","author":"Wani","year":"2008","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_19","first-page":"7012","article-title":"Mesonephric adenocarcinoma of the uterine corpus","volume":"7","author":"Wu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1066896915611489","article-title":"Mesonephric adenocarcinoma of the uterine corpus: A case report and diagnostic pitfall","volume":"24","author":"Kim","year":"2016","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: Report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13000-017-0655-y","article-title":"Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: A case report and literature review","volume":"12","author":"Ando","year":"2017","journal-title":"Diag. Pathol."},{"key":"ref_24","first-page":"S113","article-title":"A rare case of primary uterine mesonephric adenocarcinoma","volume":"149","author":"Kim","year":"2018","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/PGP.0000000000000493","article-title":"Mesonephric adenocarcinoma of the uterine corpus: Report of 2 cases and review of the literature","volume":"38","author":"Zhang","year":"2019","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"243248","DOI":"10.1016\/j.humpath.2018.08.018","article-title":"Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: Report of a case mimicking endometrioid carcinoma","volume":"86","author":"Patel","year":"2019","journal-title":"Human Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a M\u00fcllerian duct lineage: A case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diag. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/his.13798","article-title":"Pulmonary metastasis of mesonephric-like adenocarcinoma arising from the uterine body: A striking mimic of follicular thyroid carcinoma","volume":"74","author":"Yamamoto","year":"2019","journal-title":"Histopathology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-020-01012-z","article-title":"Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: A case report with complex morphological and molecular analysis","volume":"15","author":"Dundr","year":"2020","journal-title":"Diag. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.gore.2020.100657","article-title":"Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: A case report and review of the literature","volume":"34","author":"Seay","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.3802\/jgo.2019.30.e13","article-title":"The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: Hormone receptors in risk stratification","volume":"30","author":"Guan","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_33","first-page":"1504","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Modern pathology","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Off. J. US Canad. Acad. Pathol. Inc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/fon-2020-0017","article-title":"Clinicopathological study of organ metastasis in endometrial cancer","volume":"16","author":"Mao","year":"2020","journal-title":"Future Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PGP.0000000000000541","article-title":"GATA3 expression in common gynecologic carcinomas: A potential pitfall","volume":"38","author":"Terzic","year":"2019","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas","volume":"31","author":"Siami","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:22:43Z","timestamp":1760160163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040698"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040698","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}